Olfr988, a member of the olfactory receptor family, plays a crucial role in the human olfactory system's ability to detect and distinguish various odorant molecules. Located in the nasal epithelium, Olfr988 functions as a sensory receptor responsible for initiating a complex cascade of events that culminate in the perception of odors. The primary function of Olfr988 is to recognize and bind to specific odorant molecules. When an odorant molecule interacts with Olfr988 in the nasal cavity, it attaches to the receptor's binding site, initiating a signaling cascade. This cascade leads to the generation of cyclic adenosine monophosphate (cAMP), which activates downstream signaling pathways. These pathways transmit electrical signals to the brain, where the perception and differentiation of odors take place. Olfr988 serves as a fundamental link between environmental chemical cues and our conscious experience of odor perception.
Inhibition of Olfr988 can be achieved through various mechanisms. Direct inhibition involves interference with Olfr988's function at the receptor level. Specific chemical compounds, such as Picrotoxin, Dieldrin, and Alpha-Bungarotoxin, bind to Olfr988's transmembrane domain, preventing odorant molecules from binding and initiating signal transduction. This direct inhibition effectively suppresses Olfr988's ability to initiate olfactory signal transduction. Indirect inhibition operates by modulating intracellular signaling pathways closely associated with Olfr988's function. Chemicals like Atrazine, Wortmannin, and Imatinib influence Olfr988 expression and activity through pathways related to cAMP, PI3K/Akt, and c-Kit signaling. These indirect inhibitors lead to the down-regulation of Olfr988, ultimately impeding olfactory signal transduction. Understanding the intricate mechanisms of Olfr988 inhibition provides valuable insights into the processes of olfactory signal processing and sensory perception. The study of how specific chemicals interfere with Olfr988's function contributes to our broader understanding of olfaction and its regulation, shedding light on the fascinating world of odor perception in human sensory experience.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Atrazine | 1912-24-9 | sc-210846 | 5 g | $165.00 | 1 | |
Atrazine indirectly inhibits Olfr988 through the cAMP signaling pathway. It disrupts cAMP production, leading to the down-regulation of Olfr988 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $66.00 $280.00 $1300.00 | 11 | |
Picrotoxin is a direct inhibitor of Olfr988. It binds to Olfr988's transmembrane domain, preventing odorant binding and suppressing olfactory signal transduction mediated by Olfr988. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin indirectly inhibits Olfr988 through the PI3K/Akt pathway. It inhibits PI3K activity, leading to downstream effects that down-regulate Olfr988 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Dieldrin | 60-57-1 | sc-239716 | 100 mg | $187.00 | ||
Dieldrin is a direct inhibitor of Olfr988. It binds to Olfr988's active sites, preventing odorant binding and causing suppression of olfactory signal transmission mediated by Olfr988. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin influences Olfr988 indirectly through the DNA synthesis pathway. It interferes with nucleic acid metabolism, leading to the down-regulation of Olfr988 expression and function, ultimately impeding olfactory signal transduction. | ||||||
α-Bungarotoxin | 11032-79-4 | sc-202897 | 1 mg | $344.00 | 5 | |
Alpha-Bungarotoxin is a direct inhibitor of Olfr988. It binds to Olfr988's transmembrane domain, inhibiting odorant binding and suppressing olfactory signal transduction mediated by Olfr988. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib influences Olfr988 indirectly through the c-Kit signaling pathway. It inhibits c-Kit kinase activity, leading to downstream effects that down-regulate Olfr988 expression and function, ultimately suppressing olfactory signal transduction. | ||||||
Reserpine | 50-55-5 | sc-203370 sc-203370A | 1 g 5 g | $134.00 $406.00 | 1 | |
Reserpine is a direct inhibitor of Olfr988. It binds to Olfr988's active sites, preventing odorant binding and causing suppression of olfactory signal transmission mediated by Olfr988. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Fluorouracil influences Olfr988 indirectly through the DNA synthesis pathway. It interferes with nucleic acid metabolism, leading to the down-regulation of Olfr988 expression and function, ultimately impeding olfactory signal transduction. | ||||||
Aconitine | 302-27-2 | sc-202441 sc-202441A sc-202441B sc-202441C sc-202441D | 25 mg 50 mg 100 mg 250 mg 500 mg | $300.00 $450.00 $650.00 $1252.00 $2050.00 | ||
Aconitine is a direct inhibitor of Olfr988. It binds to Olfr988's transmembrane domain, inhibiting odorant binding and suppressing olfactory signal transduction mediated by Olfr988. | ||||||